References
- Park EJ, Amatya S, Kim MS, et al. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Arch Pharm Res. 2013;36:651–659.
- Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–752.
- Siafaka PI, Barmpalexis P, Lazaridou M, et al. Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: data analysis and modelling. Eur J Pharm Biopharm. 2015;94:473–484.
- Chisholm D, Gureje O, Saldivia S, et al. Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis. Bull World Health Organ. 2008;86:542–551.
- Thornley B, Rathbone J, Adams C, Awad G. Chlorpromazine versus placebo for schizophrenia. Cochrane Library. 2003:2;CD000284.
- Jafarifar E, Hajialyani M, Akbari M, et al. Preparation of a reproducible long-acting formulation of risperidone-loaded PLGA microspheres using microfluidic method. Pharm Dev Technol. 2017;22:836–843.
- Sussman N. Choosing an atypical antipsychotic. Int Clin Psychopharmacol. 2002;17:S29–S33.
- Krishnamoorthy V, Priya V, Prasad R, et al. Formulation and evaluation of risperidone–mannitol solid dispersions. FARMACIA. 2012;60:877–894.
- Eerdekens M, Van Hove I, Remmerie B, et al. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res. 2004;70:91–100.
- Su Z-X, Shi Y-N, Teng L-S, et al. Biodegradable poly (d,l-lactide-co-glycolide)(PLGA) microspheres for sustained release of risperidone: zero-order release formulation. Pharm Dev Technol. 2011;16:377–384.
- Bourges J-L, Bloquel C, Thomas A, et al. Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev. 2006;58:1182–1202.
- Tran PH-L, Tran TT-D, Park JB, et al. Controlled release systems containing solid dispersions: strategies and mechanisms. Pharm Res. 2011;28:2353–2378.
- Altamura AC, Sassella F, Santini A, et al. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. Drugs. 2003;63:493–512.
- Zhang W, Wang X, Wang S, et al. The use of injectable sonication-induced silk hydrogel for VEGF 165 and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials. 2011;32:9415–9424.
- Zhao J, Zhang Z, Wang S, et al. Apatite-coated silk fibroin scaffolds to healing mandibular border defects in canines. Bone. 2009;45:517–527.
- Nogueira GM, de Moraes MA, Rodas ACD, et al. Hydrogels from silk fibroin metastable solution: formation and characterization from a biomaterial perspective. Mater Sci Eng: C. 2011;31:997–1001.
- Rockwood DN, Preda RC, Yücel T, et al. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc. 2011;6:1612–1631.
- Yucel T, Cebe P, Kaplan DL. Vortex-induced injectable silk fibroin hydrogels. Biophys J. 2009;97:2044–2050.
- Su D, Jiang L, Chen X, et al. Enhancing the gelation and bioactivity of injectable silk fibroin hydrogel with laponite nanoplatelets. ACS Appl Mater Interfaces. 2016;8:9619–9628.
- Brown JE, Partlow BP, Berman AM, et al. Injectable silk-based biomaterials for cervical tissue augmentation: an in-vitro study. Am J Obst Gynecol. 2016;214:118. e1–1e9.
- Numata K, Katashima T, Sakai T. State of water, molecular structure, and cytotoxicity of silk hydrogels. Biomacromolecules. 2011;12:2137–2144.
- Safdari M, Shakiba E, Kiaie SH, et al. Preparation and characterization of Ceftazidime loaded electrospun silk fibroin/gelatin mat for wound dressing. Fibers Polym. 2016;17:744–750.
- Park CH, Jeong L, Cho D, et al. Effect of methylcellulose on the formation and drug release behavior of silk fibroin hydrogel. Carbohydr Polym. 2013;98:1179–1185.
- Hu X, Kaplan D, Cebe P. Determining beta-sheet crystallinity in fibrous proteins by thermal analysis and infrared spectroscopy. Macromolecules. 2006;39:6161–6170.
- Kundu J, Chung Y-I, Kim YH, et al. Silk fibroin nanoparticles for cellular uptake and control release. Int J Pharm. 2010;388:242–250.
- Zhang K-H, Yu Q-Z, Mo X-M. Fabrication and intermolecular interactions of silk fibroin/hydroxybutyl chitosan blended nanofibers. Ijms. 2011;12:2187–2199.
- Hu Z, Liu Y, Yuan W, et al. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B Biointerfaces. 2011;86:206–211.
- Mandal BB, Kapoor S, Kundu SC. Silk fibroin/polyacrylamide semi-interpenetrating network hydrogels for controlled drug release. Biomaterials. 2009;30:2826–2836.